Formalin-fixed, paraffin-embedded skin biopsy specimens, including 72 suppurative granulomatous inflammation (SGI) and 47 non-SGI controls, were tested for mycobacteria by using a broad-range PCR and a suspension array identification system. Mycobacterium smegmatis was detected in 13 (18.1%) of the SGI skin biopsy specimens, which was significantly more than 2 (4.3%) in the controls (odds ratio, 5.73; 95% confidence interval, 1.21 to 27.06; P ؍ 0.028).G ranulomatous inflammation of the skin may be broadly classified as infectious or noninfectious, with the presence of a suppurative inflammatory component often associated with the former (1-3). Suppurative granulomatous inflammation (SGI) has been defined as inflammation within the dermis and subcutis consisting of neutrophils, various numbers of eosinophils, and the presence of a histiocytic population of cells (1, 2). Multinucleated giant cells are usually present without obvious foreign material. A diagnosis may be made histologically; however, prior antibiotic exposure may "sterilize" the tissue, leading to a delayed diagnosis and increased morbidity. Tissue culture is the diagnostic gold standard, but when a mycobacterial infection is responsible, cultures often take weeks to grow (4, 5).To date, about one-third of the species of nontuberculous mycobacteria (NTM) described have been associated with human disease (5). Clinical presentations include infections of the skin and soft tissue, lymph nodes, joints, and lungs. Disseminated infections may arise following the contamination of traumatic or surgical wounds with contaminated water or other materials (5, 6). Most species of NTM have been associated with skin and soft tissue infections, but rapidly growing mycobacteria (Mycobacterium fortuitum, M. chelonae, and M. abscessus), M. marinum, and M. ulcerans have been the ones most frequently described. Some of these organisms exhibit geographic restrictions. The timely and accurate diagnosis of cutaneous NTM infections is important in that different species of these organisms have different antibiotic susceptibilities (4, 6, 7). Current laboratory techniques for identifying mycobacteria to the species level include growth in broth, nucleic acid probing, and sequencing, as well as subculture on solid medium for phenotypic testing, each of which is time intensive (4,7,8).We have developed a MycoID assay that incorporates broadrange PCR amplification with suspension array detection to identify 17 mycobacterial complexes, groups, and species in a single reaction with a detection limit of 50 to 500 copies/g of tissue (8). In this study, we have employed the MycoID procedure to detect and identify mycobacterial species in formalin-fixed, paraffin-embedded (FFPE) skin biopsy specimens exhibiting SGI and non-SGI controls.(This study was presented in part at the Association for Molecular Pathology Annual Meeting, Grapevine, TX, 17 to 19 November 2011.)Study materials. The study FFPE tissue specimens consisted of 119 skin biopsy specimens obtained from Beijing Children...